Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Pharm Ther ; 41(4): 371-82, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27245498

RESUMO

WHAT IS KNOWN AND OBJECTIVE: Optimal utilization of opioid analgesics is significantly limited by the central nervous system adverse effects and misuse/abuse potential of currently available drugs. It has been postulated that opioid-associated adverse effects and abuse potential would be greatly reduced if opioids could be excluded from reaching the brain. We review the basic science and clinical evidence of one such approach - peripherally restricted kappa-opioid receptor (KOR) agonists (pKORAs). METHODS: Published and unpublished literature, websites and other sources were searched for basic science and clinical information related to the potential benefits and development of peripherally restricted kappa-opioid receptor agonists. Each source was summarized, reviewed and assessed. RESULTS: The historical development of pKORAs can be traced from the design of increasingly KOR-selective agonists, elucidation of the pharmacologic attributes of such compounds and strategies to restrict passage across the blood-brain barrier. Novel compounds are under development and have progressed to clinical trials. WHAT IS NEW AND CONCLUSIONS: The results from recent clinical trials suggest that peripherally restricted opioids can be successfully designed and that they can retain analgesic efficacy with a more favourable adverse effect profile.


Assuntos
Analgésicos Opioides/uso terapêutico , Dor/tratamento farmacológico , Receptores Opioides kappa/agonistas , Analgésicos Opioides/efeitos adversos , Analgésicos Opioides/farmacologia , Animais , Barreira Hematoencefálica/metabolismo , Desenho de Fármacos , Humanos , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Transtornos Relacionados ao Uso de Opioides/prevenção & controle , Distribuição Tecidual
2.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 23(6): 642-4, 2001 Dec.
Artigo em Zh | MEDLINE | ID: mdl-12901115

RESUMO

OBJECTIVE: To isolate a kind of endophytic fungus which can produce taxol compounds from the bark of Taxus Cuspidata Sieb et Zucc. METHODS: Endophytic fungus was isolated from the bark of Taxus Cuspidata Sieb et Zucc by aseptic techniques and the analysis of the culture fluid from the fermentation of fungus was carried out by high performance liquid chromatography (HPLC). RESULTS: Endophytic fungus was obtained from the bark of Taxus Cuspidata Sieb et Zucc and the chemical analysis showed that the culture of fungus contain taxol compounds. CONCLUSION: Endophytic fungus which can produce taxol compounds exists in the bark of Taxus Cuspidata Sieb et Zucc.


Assuntos
Fungos/isolamento & purificação , Taxus/microbiologia , Cromatografia Líquida de Alta Pressão , Fungos/metabolismo , Paclitaxel/análise , Paclitaxel/biossíntese , Casca de Planta/microbiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA